Person · CIK 1376099

Jack Kaye

Director at uniQure and Dyadic International

Earlier: Keryx Biopharmaceuticals

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$3.2M

Noticed on Form 144$2.8M

Bought on Form 4$15K

Companies3

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

Company	Security	Held	Shares or units	As of
uniQure QURE	Ordinary Shares	Directly	25,996	Jun 30, 2026 · Filing · EDGAR
Dyadic International DYAI	Common Stock	Directly	81,201	Jan 2, 2026 · Filing · EDGAR
Dyadic International DYAI	Stock Option exercise $0.94, expires Jan 2, 2036, into Common Stock	Directly	67,500	Jan 2, 2026 · Filing · EDGAR
Dyadic International DYAI	Restricted Stock Unit into Common Stock	Directly	39,894	Jan 2, 2026 · Filing · EDGAR
Keryx Biopharmaceuticals	Common Stock	Directly	85,000	Jun 17, 2015 · Filing · EDGAR
Keryx Biopharmaceuticals	Common Stock	Owned by Spouse	1,400	Jun 19, 2007 · Filing · EDGAR

Sold and noticed by quarter

Sold (Form 4) Noticed (Form 144) Bought (Form 4)

Quarterly totals as a table

Quarter	Sold (Form 4)	Noticed (Form 144)	Bought (Form 4)
Q2 2026	$1.3M	$1.3M	—
Q1 2026	$174K	$174K	—
Q4 2025	$1.2M	$1.3M	—
Q2 2025	$31K	—	—
Q2 2024	$11K	—	—
Q2 2023	$43K	—	—
Q1 2023	$8K	Not machine-readable	—
Q1 2022	$10K	Not machine-readable	—
Q1 2021	$19K	Not machine-readable	—
Q1 2020	$50K	Not machine-readable	—
Q1 2019	$38K	Not machine-readable	—
Q1 2018	$53K	Not machine-readable	—
Q4 2010	$100K	Not machine-readable	—
Q3 2010	$125K	Not machine-readable	—
Q2 2007	—	—	$15K

Form 144 notices went onto EDGAR as structured data on April 13, 2023. Earlier notices were filed on paper and cannot be read here, so those quarters show no noticed amount.

Planned sales (Form 144) and the sales that followed

Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.

How we match

A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.

Notice date	Noticed	Planned sale	Outcome	Links
uniQure QURE · Citigroup Global Markets · 10b5-1 plan adopted Jun 16, 2025 · 5 notices
Jun 30, 2026	21,167 · ~$983K	Jun 30, 2026	Sold as noticed Sold 21,167 in 2 sales, Jun 30 to Jun 30 · $983K Form 4	Filing · EDGAR
Jun 17, 2026	5,295 · ~$225K	Jun 17, 2026	Sold as noticed Sold 5,295 at $42.57 on Jun 17 · $225K Form 4	Filing · EDGAR
Jun 3, 2026	2,645 · ~$79K	Jun 3, 2026	Sold as noticed Sold 2,645 at $30.01 on Jun 3 · $79K Form 4	Filing · EDGAR
Jan 9, 2026	6,390 · ~$174K	Jan 9, 2026	Sold as noticed Sold 6,390 at $27.28 on Jan 9 · $174K Form 4	Filing · EDGAR
Nov 4, 2025	38,810 · ~$1.3M	Nov 4, 2025	Sold as noticed Sold 38,810 in 3 sales, Nov 4 to Nov 4 · $1.2M Form 4	Filing · EDGAR
uniQure QURE · Citigroup Global Markets · No 10b5-1 plan stated · 1 notice
Jun 11, 2026	1,993 · ~$54K	Jun 11, 2026	Sold as noticed Sold 1,993 at $27.06 on Jun 11 · $54K Form 4	Filing · EDGAR
Sales without a matching Form 144 · 11 sales No matching Form 144 found. Not every sale needs one: small sales and sales by people who are not affiliates are exempt.
—	—	—	Sold without notice uniQure (QURE): Sold 2,112 at $14.45 on Jun 20, 2025 · $31K	Filing · EDGAR
—	—	—	Sold without notice uniQure (QURE): Sold 2,218 at $5.16 on Jun 13, 2024 · $11K	Filing · EDGAR
—	—	—	Sold without notice uniQure (QURE): Sold 2,280 at $18.93 on Jun 16, 2023 · $43K	Filing · EDGAR
—	—	—	Notice not machine-readable uniQure (QURE): Sold 384 at $19.99 on Feb 27, 2023 · $8K	Filing · EDGAR
—	—	—	Notice not machine-readable uniQure (QURE): Sold 600 at $16.76 on Feb 28, 2022 · $10K	Filing · EDGAR
—	—	—	Notice not machine-readable uniQure (QURE): Sold 504 at $37.60 on Mar 2, 2021 · $19K	Filing · EDGAR
—	—	—	Notice not machine-readable uniQure (QURE): Sold 806 at $62.20 on Jan 28, 2020 · $50K	Filing · EDGAR
—	—	—	Notice not machine-readable uniQure (QURE): Sold 1,210 at $31.31 on Jan 28, 2019 · $38K	Filing · EDGAR
—	—	—	Notice not machine-readable uniQure (QURE): Sold 2,878 at $18.53 on Jan 29, 2018 · $53K	Filing · EDGAR
—	—	—	Notice not machine-readable Keryx Biopharmaceuticals: Sold 20,000 at $5.00 on Dec 6, 2010 · $100K	Filing · EDGAR
—	—	—	Notice not machine-readable Keryx Biopharmaceuticals: Sold 25,000 at $5.02 on Sep 29, 2010 · $125K	Filing · EDGAR

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

uniQure QURE Director · filings 2017 to 2026 · sold $3M · $2.8M noticed on Form 144

Date	Transaction	Shares	Price	Value	Held after	Source
Jun 30, 2026	Option or RSU exercised or converted	+4,107	$37.00	$152K	30,103 direct	Filing · EDGAR
Jun 30, 2026	Sale under a 10b5-1 plan	−4,107	$46.49	$191K	25,996 direct	Filing · EDGAR
Jun 30, 2026	Option or RSU exercised or converted	+17,060	$20.18	$344K	43,056 direct	Filing · EDGAR
Jun 30, 2026	Sale under a 10b5-1 plan	−17,060	$46.43	$792K	25,996 direct	Filing · EDGAR
Jun 30, 2026	Option or RSU exercised or converted Stock Option (Right to Buy)	−4,107			0 direct	Filing · EDGAR
Jun 30, 2026	Option or RSU exercised or converted Stock Option (Right to Buy)	−17,060			0 direct	Filing · EDGAR
Jun 17, 2026	Option or RSU exercised or converted	+5,295	$31.71	$168K	31,291 direct	Filing · EDGAR
Jun 17, 2026	Sale under a 10b5-1 plan	−5,295	$42.57	$225K	25,996 direct	Filing · EDGAR
Jun 17, 2026	Option or RSU exercised or converted Stock Option (Right to Buy)	−5,295			0 direct	Filing · EDGAR
Jun 11, 2026	Open-market or private sale	−1,993	$27.06	$54K	25,996 direct	Filing · EDGAR
Jun 10, 2026	Grant or award from the company	+7,550			27,989 direct	Filing · EDGAR
Jun 10, 2026	Grant or award from the company Stock Option (Right to Buy)	+13,980			13,980 direct	Filing · EDGAR
Jun 3, 2026	Option or RSU exercised or converted	+2,645	$16.04	$42K	23,084 direct	Filing · EDGAR
Jun 3, 2026	Sale under a 10b5-1 plan	−2,645	$30.01	$79K	20,439 direct	Filing · EDGAR
Jun 3, 2026	Option or RSU exercised or converted Stock Option (Right to Buy)	−2,645			0 direct	Filing · EDGAR
Jan 9, 2026	Option or RSU exercised or converted	+6,390	$19.39	$124K	26,829 direct	Filing · EDGAR
Jan 9, 2026	Sale under a 10b5-1 plan	−6,390	$27.28	$174K	20,439 direct	Filing · EDGAR
Jan 9, 2026	Option or RSU exercised or converted Stock Option (Right to Buy)	−6,390			0 direct	Filing · EDGAR
Nov 4, 2025	Option or RSU exercised or converted	+10,000	$7.37	$74K	30,439 direct	Filing · EDGAR
Nov 4, 2025	Sale under a 10b5-1 plan	−10,000	$30.36	$304K	20,439 direct	Filing · EDGAR
Nov 4, 2025	Option or RSU exercised or converted	+11,000	$5.37	$59K	31,439 direct	Filing · EDGAR
Nov 4, 2025	Sale under a 10b5-1 plan	−11,000	$30.34	$334K	20,439 direct	Filing · EDGAR
Nov 4, 2025	Option or RSU exercised or converted	+17,810	$14.08	$251K	38,249 direct	Filing · EDGAR
Nov 4, 2025	Sale under a 10b5-1 plan	−17,810	$30.33	$540K	20,439 direct	Filing · EDGAR
Nov 4, 2025	Option or RSU exercised or converted Stock Option (Right to Buy)	−10,000			0 direct	Filing · EDGAR
Nov 4, 2025	Option or RSU exercised or converted Stock Option (Right to Buy)	−11,000			0 direct	Filing · EDGAR
Nov 4, 2025	Option or RSU exercised or converted Stock Option (Right to Buy)	−17,810			0 direct	Filing · EDGAR
Jun 20, 2025	Open-market or private sale	−2,112	$14.45	$31K	20,439 direct	Filing · EDGAR
Jun 11, 2025	Grant or award from the company	+7,970			22,551 direct	Filing · EDGAR
Jun 11, 2025	Grant or award from the company Stock Option (Right to Buy)	+15,630			15,630 direct	Filing · EDGAR
Jun 19, 2024	Grant or award from the company	+8,080			14,581 direct	Filing · EDGAR
Jun 19, 2024	Grant or award from the company Stock Option (Right to Buy)	+15,840			15,840 direct	Filing · EDGAR
Jun 13, 2024	Open-market or private sale	−2,218	$5.16	$11K	6,501 direct	Filing · EDGAR
Jun 23, 2023	Gift	−12,700			21,419 direct	Filing · EDGAR
Jun 23, 2023	Gift	−12,700			8,719 direct	Filing · EDGAR
Jun 16, 2023	Open-market or private sale	−2,280	$18.93	$43K	34,119 direct	Filing · EDGAR
Jun 13, 2023	Grant or award from the company	+8,700			36,399 direct	Filing · EDGAR
Jun 13, 2023	Grant or award from the company Stock Option (Right to Buy)	+17,060			17,060 direct	Filing · EDGAR
Feb 27, 2023	Open-market or private sale	−384	$19.99	$8K	27,699 direct	Filing · EDGAR
Jun 15, 2022	Grant or award from the company	+9,080			28,083 direct	Filing · EDGAR
Jun 15, 2022	Grant or award from the company Stock Option (Right to Buy)	+17,810			17,810 direct	Filing · EDGAR
Feb 28, 2022	Open-market or private sale	−600	$16.76	$10K	19,003 direct	Filing · EDGAR
Feb 24, 2022	Grant or award from the company	+1,534			19,603 direct	Filing · EDGAR
Feb 24, 2022	Grant or award from the company Stock Option (Right to Buy)	+2,645			2,645 direct	Filing · EDGAR
Mar 2, 2021	Open-market or private sale	−504	$37.60	$19K	18,069 direct	Filing · EDGAR
Feb 25, 2021	Grant or award from the company	+2,382			18,573 direct	Filing · EDGAR
Feb 25, 2021	Grant or award from the company Stock Option (Right to Buy)	+4,107			4,107 direct	Filing · EDGAR
Feb 27, 2020	Grant or award from the company	+2,063			16,191 direct	Filing · EDGAR
Feb 27, 2020	Grant or award from the company Stock Option (Right to Buy)	+3,620			3,620 direct	Filing · EDGAR
Jan 28, 2020	Open-market or private sale	−806	$62.20	$50K	14,128 direct	Filing · EDGAR
Jan 28, 2019	Open-market or private sale	−1,210	$31.31	$38K	14,934 direct	Filing · EDGAR
Jan 25, 2019	Grant or award from the company	+3,230			16,144 direct	Filing · EDGAR
Jan 25, 2019	Grant or award from the company Stock Option (Right to Buy)	+5,295			5,295 direct	Filing · EDGAR
Jan 29, 2018	Open-market or private sale	−2,878	$18.53	$53K	12,914 direct	Filing · EDGAR
Jan 26, 2018	Grant or award from the company	+4,792			15,792 direct	Filing · EDGAR
Jan 26, 2018	Grant or award from the company Stock Option (Right to Buy)	+6,390			6,390 direct	Filing · EDGAR
Jan 27, 2017	Grant or award from the company Stock Option (Right to Buy)	+11,000			11,000 direct	Filing · EDGAR
Jan 27, 2017	Grant or award from the company Restricted Stock Units	+11,000			11,000 direct	Filing · EDGAR

Dyadic International DYAI Director · filings 2019 to 2026

Date	Transaction	Shares	Price	Value	Held after	Source
Jan 2, 2026	Option or RSU exercised or converted	+21,552			81,201 direct	Filing · EDGAR
Jan 2, 2026	Option or RSU exercised or converted Restricted Stock Unit	−21,552			0 direct	Filing · EDGAR
Jan 2, 2026	Grant or award from the company Stock Option	+67,500			67,500 direct	Filing · EDGAR
Jan 2, 2026	Grant or award from the company Restricted Stock Unit	+39,894			39,894 direct	Filing · EDGAR
Mar 5, 2025	Option or RSU exercised or converted	+7,500	$1.33	$10K	64,666 direct	Filing · EDGAR
Mar 5, 2025	Option or RSU exercised or converted	+22,500	$1.33	$30K	87,166 direct	Filing · EDGAR
Mar 5, 2025	Shares withheld for tax or exercise price	−27,517	$1.45	$40K	59,649 direct	Filing · EDGAR
Mar 5, 2025	Option or RSU exercised or converted Stock Option	−7,500			0 direct	Filing · EDGAR
Mar 5, 2025	Option or RSU exercised or converted Stock Option	−22,500			0 direct	Filing · EDGAR
Jan 2, 2025	Option or RSU exercised or converted	+23,585			57,166 direct	Filing · EDGAR
Jan 2, 2025	Option or RSU exercised or converted Restricted Stock Unit	−23,585			0 direct	Filing · EDGAR
Jan 2, 2025	Grant or award from the company Stock Option	+67,500			67,500 direct	Filing · EDGAR
Jan 2, 2025	Grant or award from the company Restricted Stock Unit	+21,552			21,552 direct	Filing · EDGAR
Jan 3, 2024	Option or RSU exercised or converted	+27,174			33,581 direct	Filing · EDGAR
Jan 3, 2024	Option or RSU exercised or converted Restricted Stock Unit	−27,174			0 direct	Filing · EDGAR
Jan 2, 2024	Grant or award from the company Stock Option	+67,500			67,500 direct	Filing · EDGAR
Jan 2, 2024	Grant or award from the company Restricted Stock Unit	+23,585			23,585 direct	Filing · EDGAR
Jan 3, 2023	Grant or award from the company Stock Option	+52,500			52,500 direct	Filing · EDGAR
Jan 3, 2023	Grant or award from the company Restricted Stock Unit	+27,174			27,174 direct	Filing · EDGAR
Nov 21, 2022	Gift	−33,150			39,557 direct	Filing · EDGAR
Nov 21, 2022	Gift	−33,150			6,407 direct	Filing · EDGAR
Jun 10, 2022	Grant or award from the company Stock Option	+25,000			25,000 direct	Filing · EDGAR
Jan 3, 2022	Grant or award from the company Stock Option	+52,500			52,500 direct	Filing · EDGAR
Jan 4, 2021	Grant or award from the company Stock Option	+52,500			52,500 direct	Filing · EDGAR
Jan 2, 2020	Grant or award from the company Stock Option	+75,000			75,000 direct	Filing · EDGAR
Jun 25, 2019	Grant or award from the company Stock Option	+25,000			25,000 direct	Filing · EDGAR

Keryx Biopharmaceuticals Director · filings 2006 to 2015 · sold $226K · bought $15K

Date	Transaction	Shares	Price	Value	Held after	Source
Jun 17, 2015	Grant or award from the company	+10,000			85,000 direct	Filing · EDGAR
Jun 17, 2015	Grant or award from the company Stock Options (right to buy)	+30,000			30,000 direct	Filing · EDGAR
Jun 24, 2014	Grant or award from the company	+10,000			75,000 direct	Filing · EDGAR
Jun 24, 2014	Grant or award from the company Stock Options (right to buy)	+30,000			30,000 direct	Filing · EDGAR
Sep 6, 2013	Gift	−6,000	$9.13	$55K	74,000 direct	Filing · EDGAR
Sep 6, 2013	Gift	−3,000	$9.13	$27K	71,000 direct	Filing · EDGAR
Sep 6, 2013	Gift	−6,000	$9.13	$55K	65,000 direct	Filing · EDGAR
Jun 19, 2013	Grant or award from the company	+15,000			80,000 direct	Filing · EDGAR
Jun 19, 2013	Grant or award from the company Stock Options (right to buy)	+25,000			25,000 direct	Filing · EDGAR
Jun 27, 2012	Gift	−5,000	$1.81	$9K	70,000 direct	Filing · EDGAR
Jun 27, 2012	Gift	−5,000	$1.81	$9K	65,000 direct	Filing · EDGAR
Jun 20, 2012	Grant or award from the company	+15,000			75,000 direct	Filing · EDGAR
Jun 20, 2012	Grant or award from the company Stock Options (right to buy)	+25,000			25,000 direct	Filing · EDGAR
Jan 3, 2012	Gift	−9,720	$2.65	$26K	60,000 direct	Filing · EDGAR
Dec 15, 2011	Gift	−86,680	$2.42	$210K	69,720 direct	Filing · EDGAR
Jun 22, 2011	Grant or award from the company	+15,000			156,400 direct	Filing · EDGAR
Jun 22, 2011	Grant or award from the company Stock Options (Right to Buy)	+25,000			25,000 direct	Filing · EDGAR
Dec 6, 2010	Open-market or private sale	−20,000	$5.00	$100K	141,400 direct	Filing · EDGAR
Sep 29, 2010	Open-market or private sale	−25,000	$5.02	$125K	161,400 direct	Filing · EDGAR
Jun 16, 2010	Grant or award from the company	+15,000			186,400 direct	Filing · EDGAR
Jun 16, 2010	Grant or award from the company Stock Options (Right to buy)	+25,000			25,000 direct	Filing · EDGAR
Sep 19, 2009	Grant or award from the company Stock Options (Right to Buy)	+30,000			30,000 direct	Filing · EDGAR
Jun 17, 2009	Grant or award from the company Stock Options (Right to Buy)	+10,000			10,000 direct	Filing · EDGAR
Jun 16, 2009	Grant or award from the company	+75,000			171,400 direct	Filing · EDGAR
May 22, 2009	Open-market or private purchase	+35,000			96,400 direct	Filing · EDGAR
Nov 14, 2008	Grant or award from the company	+60,000			61,400 direct	Filing · EDGAR
Jun 18, 2008	Grant or award from the company Stock Options (Right to Buy)	+10,000			10,000 direct	Filing · EDGAR
Jun 21, 2007	Grant or award from the company Stock Options (Right to Buy)	+10,000			10,000 direct	Filing · EDGAR
Jun 19, 2007	Open-market or private purchase	+1,400	$10.50	$15K	1,400 Owned by Spouse	Filing · EDGAR

All 63 Forms 3, 4, 5 and 144

Filed	Form	Company	Links
Jul 2, 2026	Form 4	uniQure QURE	Filing · EDGAR
Jun 30, 2026	Form 144	uniQure QURE	Filing · EDGAR
Jun 22, 2026	Form 4	uniQure QURE	Filing · EDGAR
Jun 17, 2026	Form 144	uniQure QURE	Filing · EDGAR
Jun 12, 2026	Form 4	uniQure QURE	Filing · EDGAR
Jun 11, 2026	Form 144	uniQure QURE	Filing · EDGAR
Jun 5, 2026	Form 4	uniQure QURE	Filing · EDGAR
Jun 3, 2026	Form 144	uniQure QURE	Filing · EDGAR
Jan 12, 2026	Form 4	uniQure QURE	Filing · EDGAR
Jan 9, 2026	Form 144	uniQure QURE	Filing · EDGAR
Jan 6, 2026	Form 4	Dyadic International DYAI	Filing · EDGAR
Nov 6, 2025	Form 4	uniQure QURE	Filing · EDGAR
Nov 4, 2025	Form 144	uniQure QURE	Filing · EDGAR
Jun 24, 2025	Form 4	uniQure QURE	Filing · EDGAR
Jun 13, 2025	Form 4	uniQure QURE	Filing · EDGAR
Mar 7, 2025	Form 4	Dyadic International DYAI	Filing · EDGAR
Jan 7, 2025	Form 4	Dyadic International DYAI	Filing · EDGAR
Jun 21, 2024	Form 4	uniQure QURE	Filing · EDGAR
Jun 17, 2024	Form 4	uniQure QURE	Filing · EDGAR
Feb 6, 2024	Form 5	uniQure QURE	Filing · EDGAR
Jan 4, 2024	Form 4	Dyadic International DYAI	Filing · EDGAR
Jun 20, 2023	Form 4	uniQure QURE	Filing · EDGAR
Mar 1, 2023	Form 4	uniQure QURE	Filing · EDGAR
Jan 5, 2023	Form 5	Dyadic International DYAI	Filing · EDGAR
Jan 5, 2023	Form 4	Dyadic International DYAI	Filing · EDGAR
Jun 17, 2022	Form 4	uniQure QURE	Filing · EDGAR
Jun 14, 2022	Form 4	Dyadic International DYAI	Filing · EDGAR
Mar 2, 2022	Form 4	uniQure QURE	Filing · EDGAR
Feb 28, 2022	Form 4	uniQure QURE	Filing · EDGAR
Jan 5, 2022	Form 4	Dyadic International DYAI	Filing · EDGAR
Mar 4, 2021	Form 4	uniQure QURE	Filing · EDGAR
Mar 1, 2021	Form 4	uniQure QURE	Filing · EDGAR
Jan 6, 2021	Form 4	Dyadic International DYAI	Filing · EDGAR
Mar 2, 2020	Form 4	uniQure QURE	Filing · EDGAR
Jan 30, 2020	Form 4	uniQure QURE	Filing · EDGAR
Jan 3, 2020	Form 4	Dyadic International DYAI	Filing · EDGAR
Jun 27, 2019	Form 4	Dyadic International DYAI	Filing · EDGAR
Feb 13, 2019	Form 3	Dyadic International DYAI	Filing · EDGAR
Jan 31, 2019	Form 4	uniQure QURE	Filing · EDGAR
Jan 31, 2019	Form 4	uniQure QURE	Filing · EDGAR
Jan 31, 2018	Form 4	uniQure QURE	Filing · EDGAR
Jan 30, 2018	Form 4	uniQure QURE	Filing · EDGAR
Jan 31, 2017	Form 4	uniQure QURE	Filing · EDGAR
Jan 10, 2017	Form 3	uniQure QURE	Filing · EDGAR
Jun 18, 2015	Form 4	Keryx Biopharmaceuticals	Filing · EDGAR
Jun 26, 2014	Form 4	Keryx Biopharmaceuticals	Filing · EDGAR
Sep 9, 2013	Form 4	Keryx Biopharmaceuticals	Filing · EDGAR
Jun 21, 2013	Form 4	Keryx Biopharmaceuticals	Filing · EDGAR
Feb 15, 2013	Form 4	Keryx Biopharmaceuticals	Filing · EDGAR
Jun 22, 2012	Form 4	Keryx Biopharmaceuticals	Filing · EDGAR
Jan 4, 2012	Form 4	Keryx Biopharmaceuticals	Filing · EDGAR
Dec 19, 2011	Form 4	Keryx Biopharmaceuticals	Filing · EDGAR
Jul 13, 2011	Form 4	Keryx Biopharmaceuticals	Filing · EDGAR
Dec 8, 2010	Form 4	Keryx Biopharmaceuticals	Filing · EDGAR
Oct 1, 2010	Form 4	Keryx Biopharmaceuticals	Filing · EDGAR
Jun 18, 2010	Form 4	Keryx Biopharmaceuticals	Filing · EDGAR
Sep 22, 2009	Form 4	Keryx Biopharmaceuticals	Filing · EDGAR
Jun 18, 2009	Form 4	Keryx Biopharmaceuticals	Filing · EDGAR
May 22, 2009	Form 4	Keryx Biopharmaceuticals	Filing · EDGAR
Nov 18, 2008	Form 4	Keryx Biopharmaceuticals	Filing · EDGAR
Jun 20, 2008	Form 4	Keryx Biopharmaceuticals	Filing · EDGAR
Jun 22, 2007	Form 4	Keryx Biopharmaceuticals	Filing · EDGAR
Sep 22, 2006	Form 3	Keryx Biopharmaceuticals	Filing · EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched Nov 6, 2026, 7:08 PM ET. The filing on SEC.gov is the record.